drugset / Trial / NCT01231451

Depot Contraception With and Without Lopinavir/Ritonavir

NCT01231451 ↗

Phase 1 Withdrawn 10 enrolled St Stephens Aids Trust
NaSingle-groupOpen-labelPrevention

Summary

DMPA (depot medroxyprogesterone acetate or the 'depot' injection) is a widely used contraception. It is popular in woman with HIV as it probably still works when you take HIV drugs. HIV drugs can increase or decrease the level of other drugs (e.g. contraceptives) in your bloodstream which may make them work less well or increase side effects. It is assumed that DMPA can be given with HIV drugs there are no studies proving this. The purpose of the study is to investigate whether an HIV drug combination containing lopinavir/ritonavir affects DMPA when they are taken at the same time.

Timeline

Start
2010-12
Primary completion
2011-06
Completion
2011-06

Outcome

Outcome not reported

Stopped: “Ethics board said the study could not be fully justified.”

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified — —